DE2710047C2 - - Google Patents

Info

Publication number
DE2710047C2
DE2710047C2 DE2710047A DE2710047A DE2710047C2 DE 2710047 C2 DE2710047 C2 DE 2710047C2 DE 2710047 A DE2710047 A DE 2710047A DE 2710047 A DE2710047 A DE 2710047A DE 2710047 C2 DE2710047 C2 DE 2710047C2
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2710047A
Other languages
German (de)
Other versions
DE2710047A1 (de
Inventor
Marcel Rosieres Be Descamps
Charles Bruessel/Bruxelles Be Goldenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of DE2710047A1 publication Critical patent/DE2710047A1/de
Application granted granted Critical
Publication of DE2710047C2 publication Critical patent/DE2710047C2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19772710047 1976-03-08 1977-03-08 Substituierte sulfonamidverbindungen und deren herstellung und verwendung Granted DE2710047A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9253/76A GB1521932A (en) 1976-03-08 1976-03-08 Sulphonamide derivatives and process for preparing the same

Publications (2)

Publication Number Publication Date
DE2710047A1 DE2710047A1 (de) 1977-09-15
DE2710047C2 true DE2710047C2 (US07202987-20070410-C00007.png) 1987-03-19

Family

ID=9868412

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772710047 Granted DE2710047A1 (de) 1976-03-08 1977-03-08 Substituierte sulfonamidverbindungen und deren herstellung und verwendung

Country Status (9)

Country Link
US (1) US4117151A (US07202987-20070410-C00007.png)
JP (1) JPS6056714B2 (US07202987-20070410-C00007.png)
BE (1) BE852141A (US07202987-20070410-C00007.png)
CH (1) CH620915A5 (US07202987-20070410-C00007.png)
DE (1) DE2710047A1 (US07202987-20070410-C00007.png)
ES (1) ES456610A1 (US07202987-20070410-C00007.png)
FR (1) FR2343736A1 (US07202987-20070410-C00007.png)
GB (1) GB1521932A (US07202987-20070410-C00007.png)
NL (1) NL7702275A (US07202987-20070410-C00007.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2727802A1 (de) * 1977-06-21 1979-04-19 Hoechst Ag Sulfamoyl-arylketone und verfahren zu ihrer herstellung
EP0223124B1 (en) * 1985-11-06 1991-06-12 Merck & Co. Inc. Substituted aminosulfonyl 6-nitrobenzoic-esters or amides, processes for their preparation and pharmaceutical compositions containing them
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
US5179095A (en) * 1986-02-26 1993-01-12 Eisai Co., Ltd. Piperidine derivative and pharmaceutical composition containing the same
US4831054A (en) * 1988-04-18 1989-05-16 Taro Pharmaceuticals, Ltd. 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
JPH04118410U (ja) * 1991-03-29 1992-10-22 株式会社 筒井太郎商店 縫製手袋
CA2208011A1 (en) * 1994-12-20 1996-06-27 F. Hoffmann-La Roche Ag Aryl-and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
US6103708A (en) * 1998-05-12 2000-08-15 American Home Products Corporation Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia
US6699896B1 (en) 1998-05-12 2004-03-02 Wyeth Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
CN1308604A (zh) 1998-05-12 2001-08-15 美国家用产品公司 用于治疗胰岛素抗性和高血糖的2,3,5-取代的联苯化合物
US6451827B2 (en) 1998-05-12 2002-09-17 Wyeth 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6221902B1 (en) 1998-05-12 2001-04-24 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
US6110963A (en) * 1998-05-12 2000-08-29 American Home Products Corporation Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
CA2428266A1 (en) * 2000-11-10 2002-05-16 Actelion Pharmaceuticals Ltd. Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
US7420055B2 (en) 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
WO2012048058A2 (en) * 2010-10-06 2012-04-12 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action

Also Published As

Publication number Publication date
FR2343736B1 (US07202987-20070410-C00007.png) 1980-02-08
JPS52116446A (en) 1977-09-29
US4117151A (en) 1978-09-26
ES456610A1 (es) 1978-01-16
CH620915A5 (US07202987-20070410-C00007.png) 1980-12-31
BE852141A (fr) 1977-09-07
JPS6056714B2 (ja) 1985-12-11
GB1521932A (en) 1978-08-16
NL7702275A (nl) 1977-09-12
DE2710047A1 (de) 1977-09-15
FR2343736A1 (fr) 1977-10-07

Similar Documents

Publication Publication Date Title
FR2363635B1 (US07202987-20070410-C00007.png)
FR2343736B1 (US07202987-20070410-C00007.png)
JPS5419809B2 (US07202987-20070410-C00007.png)
DK589476A (US07202987-20070410-C00007.png)
JPS52102819U (US07202987-20070410-C00007.png)
JPS5386363U (US07202987-20070410-C00007.png)
JPS5431129Y2 (US07202987-20070410-C00007.png)
JPS5516763B2 (US07202987-20070410-C00007.png)
JPS5313283U (US07202987-20070410-C00007.png)
JPS5342869U (US07202987-20070410-C00007.png)
JPS5349505U (US07202987-20070410-C00007.png)
JPS5368338U (US07202987-20070410-C00007.png)
JPS5383061U (US07202987-20070410-C00007.png)
CH598430A5 (US07202987-20070410-C00007.png)
CH598094A5 (US07202987-20070410-C00007.png)
CH600247A5 (US07202987-20070410-C00007.png)
CH600253A5 (US07202987-20070410-C00007.png)
CH601730A5 (US07202987-20070410-C00007.png)
CH602400A5 (US07202987-20070410-C00007.png)
CH603294A5 (US07202987-20070410-C00007.png)
CH603538A5 (US07202987-20070410-C00007.png)
CH604063A5 (US07202987-20070410-C00007.png)
CH604962A5 (US07202987-20070410-C00007.png)
CH605109A5 (US07202987-20070410-C00007.png)
CH606631A5 (US07202987-20070410-C00007.png)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee